Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review

J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1636-1638. doi: 10.1016/j.jaip.2019.01.056. Epub 2019 Feb 15.

Authors

Giuseppe Fabio Parisi¹, Anna Portale², Maria Papale², Lucia Tardino², Novella Rotolo², Amelia Licari³, Salvatore Leonardi²

Affiliations

¹ Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. Electronic address: giuseppeparisi88@hotmail.it.
² Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
³ Department of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

PMID: 30772479
DOI: 10.1016/j.jaip.2019.01.056

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't
Review

MeSH terms

Adolescent
Adrenal Cortex Hormones / therapeutic use
Adult
Anti-Allergic Agents / therapeutic use*
Antifungal Agents / therapeutic use
Aspergillosis, Allergic Bronchopulmonary / complications
Aspergillosis, Allergic Bronchopulmonary / drug therapy*
Aspergillosis, Allergic Bronchopulmonary / physiopathology
Child
Cystic Fibrosis / complications
Cystic Fibrosis / physiopathology*
Forced Expiratory Volume
Humans
Male
Omalizumab / therapeutic use*
Treatment Failure
Treatment Outcome

Substances

Adrenal Cortex Hormones
Anti-Allergic Agents
Antifungal Agents
Omalizumab